Currenc Group, Inc. (CURR)

USD 1.41

(-0.28%)

Operating Expenses Summary of Currenc Group, Inc.

  • Currenc Group, Inc.'s latest annual operating expenses in 2023 was 24 Million USD , up 104.71% from previous year.
  • Currenc Group, Inc.'s latest quarterly operating expenses in 2024 Q2 was 944 Thousand USD , down -83.8% from previous quarter.
  • Currenc Group, Inc. reported a annual operating expenses of 11.72 Million USD in annual operating expenses 2022, down -44.82% from previous year.
  • Currenc Group, Inc. reported a annual operating expenses of 21.24 Million USD in annual operating expenses 2021, up 50.13% from previous year.
  • Currenc Group, Inc. reported a quarterly operating expenses of 5.82 Million USD for 2024 Q1, down -21.77% from previous quarter.
  • Currenc Group, Inc. reported a quarterly operating expenses of 2.54 Million USD for 2023 Q2, down -2.87% from previous quarter.

Annual Operating Expenses Chart of Currenc Group, Inc. (2023 - 2014)

Historical Annual Operating Expenses of Currenc Group, Inc. (2023 - 2014)

Year Operating Expenses Operating Expenses Growth
2023 24 Million USD 104.71%
2022 11.72 Million USD -44.82%
2021 21.24 Million USD 50.13%
2020 14.15 Million USD 13.9%
2019 12.42 Million USD 58.07%
2018 7.86 Million USD 7.08%
2017 7.34 Million USD 90.35%
2016 3.85 Million USD 140.77%
2015 1.6 Million USD 172.52%
2014 587.83 Thousand USD 0.0%

Peer Operating Expenses Comparison of Currenc Group, Inc.

Name Operating Expenses Operating Expenses Difference
ANI Pharmaceuticals, Inc. 195.98 Million USD 87.753%
Aquestive Therapeutics, Inc. 44.85 Million USD 46.488%
Collegium Pharmaceutical, Inc. 159.2 Million USD 84.924%
Cosmos Health Inc. 26.18 Million USD 8.322%
Cyclo Therapeutics, Inc. 21.04 Million USD -14.067%
Esperion Therapeutics, Inc. 271.89 Million USD 91.172%
Cronos Group Inc. 96.7 Million USD 75.181%
Incannex Healthcare Limited 30.05 Million USD 20.134%
Kala Pharmaceuticals, Inc. 39.15 Million USD 38.697%
Lifecore Biomedical, Inc. 49.03 Million USD 51.054%
Regencell Bioscience Holdings Limited 3.99 Million USD -501.385%
Sunshine Biopharma, Inc. 13.12 Million USD -82.88%
Sunshine Biopharma, Inc. 13.12 Million USD -82.88%
SCYNEXIS, Inc. 51.84 Million USD 53.707%
Safety Shot Inc 12.1 Million USD -98.206%
Theratechnologies Inc. 72.75 Million USD 67.01%
Alpha Teknova, Inc. 45.85 Million USD 47.661%
Universe Pharmaceuticals INC 13.84 Million USD -73.402%
Pacira BioSciences, Inc. 326.37 Million USD 92.646%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD -154.098%
Dynavax Technologies Corporation 219.14 Million USD 89.047%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 89.66%
Radius Health, Inc. 265.92 Million USD 90.974%
China SXT Pharmaceuticals, Inc. 3.06 Million USD -682.034%
Alvotech 285.43 Million USD 91.591%
Intra-Cellular Therapies, Inc. 590 Million USD 95.932%
SIGA Technologies, Inc. 22.04 Million USD -8.887%
Shineco, Inc. 17.94 Million USD -33.731%
Silver Spike Investment Corp. 762.49 Thousand USD -3047.848%
Journey Medical Corporation 54.59 Million USD 56.035%
Petros Pharmaceuticals, Inc. 17.8 Million USD -34.779%
Embecta Corp. 528.4 Million USD 95.458%
Harrow Health, Inc. 89.97 Million USD 73.323%
Procaps Group, S.A. 199.47 Million USD 87.967%
Biofrontera Inc. 39.95 Million USD 39.933%
DURECT Corporation 43.71 Million USD 45.094%
PainReform Ltd. 9.58 Million USD -150.439%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 95.463%
OptiNose, Inc. 85.1 Million USD 71.796%
RedHill Biopharma Ltd. -9.56 Million USD 351.042%
Organogenesis Holdings Inc. 314.13 Million USD 92.359%
Cumberland Pharmaceuticals Inc. 43.04 Million USD 44.234%
ProPhase Labs, Inc. 37.85 Million USD 36.59%
Phibro Animal Health Corporation 260.29 Million USD 90.779%
Procaps Group S.A. 187.24 Million USD 87.181%
TherapeuticsMD, Inc. 9.82 Million USD -144.296%
Viatris Inc. 5.96 Billion USD 99.598%
Rockwell Medical, Inc. 15.37 Million USD -56.121%
Aytu BioPharma, Inc. 59.84 Million USD 59.89%
Tilray Brands, Inc. 251.35 Million USD 90.451%
PetIQ, Inc. 192.72 Million USD 87.546%
Talphera, Inc. 11.99 Million USD -100.117%
Neurocrine Biosciences, Inc. 1.59 Billion USD 98.497%
Alimera Sciences, Inc. 62.64 Million USD 61.683%
Assertio Holdings, Inc. 368.58 Million USD 93.488%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD -307.812%
Avadel Pharmaceuticals plc 164.96 Million USD 85.45%
Hempacco Co., Inc. 7.59 Million USD -215.965%
Alvotech 285.43 Million USD 91.591%
Lantheus Holdings, Inc. 344.9 Million USD 93.041%
Kamada Ltd. 45.42 Million USD 47.162%
Indivior PLC 911 Million USD 97.365%
Evoke Pharma, Inc. 12.4 Million USD -93.415%
Flora Growth Corp. 10.57 Million USD -126.884%
Cyclo Therapeutics, Inc. 21.04 Million USD -14.067%
Evolus, Inc. 189.75 Million USD 87.351%
HUTCHMED (China) Limited 436.23 Million USD 94.498%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD 84.428%
Akanda Corp. 3.48 Million USD -589.021%